HEADER IMMUNE SYSTEM/INHIBITOR 10-JAN-19 6NM7 TITLE PD-L1 IGV DOMAIN BOUND TO FRAGMENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROGRAMMED CELL DEATH 1 LIGAND 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROGRAMMED DEATH LIGAND 1,B7 HOMOLOG 1,B7-H1; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FRAGMENT-BASED SCREENING, STRUCTURE-BASED DESIGN, PD-L1 INHIBITOR, KEYWDS 2 CANCER DRUG DISCOVERY, IMMUNOTHERAPY, IMMUNE SYSTEM, IMMUNE SYSTEM- KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.PERRY,B.ZHAO REVDAT 4 11-OCT-23 6NM7 1 REMARK REVDAT 3 27-NOV-19 6NM7 1 REMARK REVDAT 2 27-FEB-19 6NM7 1 JRNL REVDAT 1 20-FEB-19 6NM7 0 JRNL AUTH E.PERRY,J.J.MILLS,B.ZHAO,F.WANG,Q.SUN,P.P.CHRISTOV,J.C.TARR, JRNL AUTH 2 T.A.RIETZ,E.T.OLEJNICZAK,T.LEE,S.FESIK JRNL TITL FRAGMENT-BASED SCREENING OF PROGRAMMED DEATH LIGAND 1 JRNL TITL 2 (PD-L1). JRNL REF BIOORG. MED. CHEM. LETT. V. 29 786 2019 JRNL REFN ESSN 1464-3405 JRNL PMID 30728114 JRNL DOI 10.1016/J.BMCL.2019.01.028 REMARK 2 REMARK 2 RESOLUTION. 2.43 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.43 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.16 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 10113 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 492 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.1578 - 3.8492 1.00 2521 144 0.1810 0.2582 REMARK 3 2 3.8492 - 3.0560 1.00 2411 122 0.1869 0.2397 REMARK 3 3 3.0560 - 2.6699 1.00 2365 123 0.2316 0.2918 REMARK 3 4 2.6699 - 2.4259 0.98 2324 103 0.2747 0.3524 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.69 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6NM7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1000238819. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-AUG-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10155 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.426 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.13500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.43 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.47 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.70 REMARK 200 R MERGE FOR SHELL (I) : 0.87800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6NP9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.056 M NAH2PO4, 1.344 M K2HPO4, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 41.45550 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.46050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.45550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.46050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 17 REMARK 465 HIS A 144 REMARK 465 HIS A 145 REMARK 465 MET B 17 REMARK 465 HIS B 144 REMARK 465 HIS B 145 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 45 CG CD OE1 OE2 REMARK 470 GLN A 47 CG CD OE1 NE2 REMARK 470 GLU B 45 CG CD OE1 OE2 REMARK 470 GLN B 47 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 45 -80.67 -56.46 REMARK 500 LYS A 46 -72.78 -110.20 REMARK 500 GLU A 60 59.57 29.19 REMARK 500 ASP A 61 -0.92 84.60 REMARK 500 GLN A 83 -7.24 84.46 REMARK 500 LEU A 88 91.11 -68.74 REMARK 500 ASP A 103 71.27 64.00 REMARK 500 TYR A 118 79.85 -156.37 REMARK 500 GLN B 47 141.76 61.99 REMARK 500 GLU B 60 54.09 34.61 REMARK 500 HIS B 69 78.66 43.76 REMARK 500 TYR B 118 73.15 -151.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 22L B 201 DBREF 6NM7 A 19 134 UNP Q9NZQ7 PD1L1_HUMAN 19 134 DBREF 6NM7 B 19 134 UNP Q9NZQ7 PD1L1_HUMAN 19 134 SEQADV 6NM7 MET A 17 UNP Q9NZQ7 INITIATING METHIONINE SEQADV 6NM7 ALA A 18 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 THR A 76 UNP Q9NZQ7 VAL 76 ENGINEERED MUTATION SEQADV 6NM7 ALA A 135 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 ALA A 136 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 ALA A 137 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 LEU A 138 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 GLU A 139 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS A 140 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS A 141 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS A 142 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS A 143 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS A 144 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS A 145 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 MET B 17 UNP Q9NZQ7 INITIATING METHIONINE SEQADV 6NM7 ALA B 18 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 THR B 76 UNP Q9NZQ7 VAL 76 ENGINEERED MUTATION SEQADV 6NM7 ALA B 135 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 ALA B 136 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 ALA B 137 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 LEU B 138 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 GLU B 139 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS B 140 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS B 141 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS B 142 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS B 143 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS B 144 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM7 HIS B 145 UNP Q9NZQ7 EXPRESSION TAG SEQRES 1 A 129 MET ALA PHE THR VAL THR VAL PRO LYS ASP LEU TYR VAL SEQRES 2 A 129 VAL GLU TYR GLY SER ASN MET THR ILE GLU CYS LYS PHE SEQRES 3 A 129 PRO VAL GLU LYS GLN LEU ASP LEU ALA ALA LEU ILE VAL SEQRES 4 A 129 TYR TRP GLU MET GLU ASP LYS ASN ILE ILE GLN PHE VAL SEQRES 5 A 129 HIS GLY GLU GLU ASP LEU LYS THR GLN HIS SER SER TYR SEQRES 6 A 129 ARG GLN ARG ALA ARG LEU LEU LYS ASP GLN LEU SER LEU SEQRES 7 A 129 GLY ASN ALA ALA LEU GLN ILE THR ASP VAL LYS LEU GLN SEQRES 8 A 129 ASP ALA GLY VAL TYR ARG CYS MET ILE SER TYR GLY GLY SEQRES 9 A 129 ALA ASP TYR LYS ARG ILE THR VAL LYS VAL ASN ALA PRO SEQRES 10 A 129 TYR ALA ALA ALA LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 129 MET ALA PHE THR VAL THR VAL PRO LYS ASP LEU TYR VAL SEQRES 2 B 129 VAL GLU TYR GLY SER ASN MET THR ILE GLU CYS LYS PHE SEQRES 3 B 129 PRO VAL GLU LYS GLN LEU ASP LEU ALA ALA LEU ILE VAL SEQRES 4 B 129 TYR TRP GLU MET GLU ASP LYS ASN ILE ILE GLN PHE VAL SEQRES 5 B 129 HIS GLY GLU GLU ASP LEU LYS THR GLN HIS SER SER TYR SEQRES 6 B 129 ARG GLN ARG ALA ARG LEU LEU LYS ASP GLN LEU SER LEU SEQRES 7 B 129 GLY ASN ALA ALA LEU GLN ILE THR ASP VAL LYS LEU GLN SEQRES 8 B 129 ASP ALA GLY VAL TYR ARG CYS MET ILE SER TYR GLY GLY SEQRES 9 B 129 ALA ASP TYR LYS ARG ILE THR VAL LYS VAL ASN ALA PRO SEQRES 10 B 129 TYR ALA ALA ALA LEU GLU HIS HIS HIS HIS HIS HIS HET 22L B 201 16 HETNAM 22L 5-PHENYLTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE FORMUL 3 22L C12 H8 N2 O S FORMUL 4 HOH *21(H2 O) HELIX 1 AA1 ASP A 49 ALA A 52 5 4 HELIX 2 AA2 LEU A 88 LEU A 94 1 7 HELIX 3 AA3 LYS A 105 ALA A 109 5 5 HELIX 4 AA4 PRO A 133 HIS A 143 1 11 HELIX 5 AA5 HIS B 78 ARG B 82 5 5 HELIX 6 AA6 LYS B 89 LEU B 94 5 6 HELIX 7 AA7 LYS B 105 ALA B 109 5 5 HELIX 8 AA8 PRO B 133 HIS B 143 1 11 SHEET 1 AA1 6 LEU A 27 GLU A 31 0 SHEET 2 AA1 6 ALA A 121 ASN A 131 1 O ASN A 131 N VAL A 30 SHEET 3 AA1 6 GLY A 110 SER A 117 -1 N TYR A 112 O ILE A 126 SHEET 4 AA1 6 ILE A 54 MET A 59 -1 N GLU A 58 O ARG A 113 SHEET 5 AA1 6 LYS A 62 VAL A 68 -1 O PHE A 67 N VAL A 55 SHEET 6 AA1 6 GLU A 71 GLU A 72 -1 O GLU A 71 N VAL A 68 SHEET 1 AA2 3 MET A 36 ILE A 38 0 SHEET 2 AA2 3 LEU A 99 ILE A 101 -1 O LEU A 99 N ILE A 38 SHEET 3 AA2 3 ALA A 85 LEU A 87 -1 N ARG A 86 O GLN A 100 SHEET 1 AA3 6 LEU B 27 GLU B 31 0 SHEET 2 AA3 6 ALA B 121 ASN B 131 1 O ASN B 131 N VAL B 30 SHEET 3 AA3 6 GLY B 110 SER B 117 -1 N TYR B 112 O ILE B 126 SHEET 4 AA3 6 ILE B 54 MET B 59 -1 N TYR B 56 O MET B 115 SHEET 5 AA3 6 LYS B 62 VAL B 68 -1 O PHE B 67 N VAL B 55 SHEET 6 AA3 6 GLU B 71 ASP B 73 -1 O ASP B 73 N GLN B 66 SHEET 1 AA4 3 MET B 36 LYS B 41 0 SHEET 2 AA4 3 ASN B 96 ILE B 101 -1 O ALA B 97 N CYS B 40 SHEET 3 AA4 3 ALA B 85 LEU B 87 -1 N ARG B 86 O GLN B 100 SSBOND 1 CYS A 40 CYS A 114 1555 1555 2.05 SSBOND 2 CYS B 40 CYS B 114 1555 1555 2.02 SITE 1 AC1 11 ILE A 54 TYR A 56 MET A 115 ILE A 116 SITE 2 AC1 11 SER A 117 ASP A 122 MET B 115 ILE B 116 SITE 3 AC1 11 ALA B 121 ASP B 122 TYR B 123 CRYST1 82.911 94.921 32.155 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012061 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010535 0.000000 0.00000 SCALE3 0.000000 0.000000 0.031099 0.00000